Search

22 Feb 2023: Predictimmune will develop similar predictive tests for other significant diseases, which fall into the same immune-mediated category, including lupus, multiple sclerosis, diabetes mellitus, rheumatoid arthritis and transplantation complications.

19 Feb 2024: Group Blogs Archives - Primary Care Unit https://www.phpc.cam.ac.uk/pcu/category/group-blogs/ Department of Public Health & Primary Care Thu, 30 Nov 2023 10:59:22 0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 Sensing technology is set to

Yonath (Weizmann Institute of Science, Israel). The trio showed how the information encoded on strands of DNA […]. Human Antibodies developed for Treatment of Lupus and Anthrax. ... treat lupus, a potentially fatal autoimmune disease, and anthrax, a

23 Feb 2024: This is a collaboration between clinicians, basic scientists and bioinformaticians that aims to apply expression profiling to the clinical management of autoimmune diseases such as systemic lupus erythematosus and small vessel ... Jolly, EC, Watts, R, Lau

23 Feb 2024: In June 2013, I joined a postdoctoral research fellowship at the Vasculitis and Lupus Clinic under the supervision of  Dr David Jayne.

23 Feb 2024: Wellcome Trust Senior Investigator. Honorary Consultant, Vasculitis and Lupus Clinic, Cambridge University Hospitals.

15 May 2024: Women with pre-gestational health conditions such as endometriosis, diabetes, obesity and Lupus are at high risk of either early pregnancy loss or developing pregnancy complications.

We have a particular interest in how tissue immune cells work with epithelial cells to defend the kidney from infection but play pathogenic roles in autoimmune diseases like lupus nephritis or ... strongDistinct pathogenic roles for resident and

19 Feb 2024: delays contributed to potentially avoidable deaths: ‘I don’t think they would have died if they’d come in earlier,’ said another consultant, discussing two lupus patients./p pSome patients reported ... on the telephone.’ (Patient with lupus)/p

Lupus Loop. Right Ascension: 15 10 00. Declination: 40 00. Size (/arcmin): 180?

23 Feb 2024: {"id":26,"date":"2011-03-01T14:00:13","date_gmt":"2011-03-01T14:00:13","guid":{"rendered":"http://cscs32.medschl.cam.ac.uk/infectious-diseases/?page_id=26"},"modified":"2016-11-09T14:03:38","modified_gmt":"2016-11-09T14:03:38","slug":"publications","

Lupus Loop 330.2 1.0 16 01 06 -51 34 11 S?

23 Feb 2024: To compare lupus and related disease patients’ wellbeing, mental health and perception of medical care with patients with RA, fibromyalgia and healthy friend controls.

19 Feb 2024: delays contributed to potentially avoidable deaths: ‘I don’t think they would have died if they’d come in earlier,’ said another consultant, discussing two lupus patients./p pSome patients reported ... on the telephone.’ (Patient with lupus)/p

Quick Links. For staff. For alumni. For business. Colleges & departments. Libraries & facilities. Museums & collections. Email & phone search. Site Search. Site Search. Publications. CIDDRG. Publications.. Publications by members of CIDDRG are

23 Feb 2024: Prof David Jayne, Director of the Vasculitis and Lupus Service, Cambridge University Hospitals NHS Foundation Trust. -

23 Feb 2024: 01223 762127. Honorary Consultant, Vasculitis and Lupus Clinic, Cambridge University Hospitals.

New drug Benlysta in Lupus treatment. ... Published on. 15 June, 2011. “Benlysta emerges as a direct approach in lupus treatment.

23 Feb 2024: Data Integration: A Study Case in Systematic Lupus Erythematosus.

23 Feb 2024: lupus erythematosus</li> <li>autoimmune diseases</li> <li>atherosclerosis</li> <li>immunotherapy</li> <li>glomerular disease</li> <li>chronic inflammation</li> <li>vasculitis</li> <li>Wegener's granulomatosis</li> <li>ANCA

PMID: 23172560. Auto-immune cholangiopathy in a juvenile patient with systemic lupus erythematosus.

uploads/2019/03/DavidJayne-HQ-819x1024.jpg 819w" sizes="(max-width: 240px) 100vw, 240px" //a/pnpClinical evaluation of newer immunotherapeutics in vasculitis, lupus and immune-mediated renal disease.

23 Feb 2024: Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis.

DOI: 10.1038/s41598-017-12740-6/pnpbMartin J/b, Ponstingl H u2026 Bradley A;Comprehensive annotation and evolutionary insights into the canine (Canis lupus familiaris) antigen receptor loci.

Systemic lupus erythematosus. ... Systemic lupus erythematosus. 3094. 489836.

Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients. ... An audit of recording cardiovascular risk factors in patients with rheumatoid arthritis and systemic lupus erythematosus in

They include tests for lupus, multiple sclerosis, diabetes mellitus and rheumatoid arthritis./pnpbProfessor Arthur Kaser/b/pn","protected":false},"excerpt":{"rendered":"pOne in every three-hundred people has inflammatory bowel disease

to Lead Developments in Immune-Mediated Disease/h1npCITIID is already driving therapeutic breakthroughs in immune-mediated disease such as inflammatory bowel disease and systemic lupus erythematosus.

23 Feb 2024: The consortia funded in this round cover a spectrum of diseases from the rare condition Systemic Lupus Erythematosus to more common conditions affecting millions of patients. ... The MASTERPLANS team will work to identify factors that predict which

23 Feb 2024: Search site. Cambridge Immunology Network. Professor Ken Smith. Ken Smith established the Cambridge Immunology Strategic Research Network, which unifies both basic and translational immunological research across the broader Cambridge area. He also

17 May 2024: Search site. Research Operations Office. Common Values - Funder. This page shows funders that are available in X5. You can search for an item using the box below. Enter some text to filter your results. Code. Name. 1907FDN. 1907 Foundation

22 Feb 2023: long-term value.”. Immune-mediated diseases, such as inflammatory bowel disease, vasculitis and Lupus are common, chronic and incurable, and there is currently no way of knowing whether a patient is

23 Feb 2024: My main research interests are related to the Pharmacogenomics of monoclonal antibodies in autoimmune diseases-renal immune mediated processes (vasculitis, systemic lupus erithematosus, membranous nephropathy).

23 Feb 2024: lupus erythematosus</li> <li>autoimmune diseases</li> <li>atherosclerosis</li> <li>immunotherapy</li> <li>glomerular disease</li> <li>chronic inflammation</li> <li>vasculitis</li> <li>Wegener's granulomatosis</li> <li>ANCA

23 Feb 2024: lupus erythematosus</li> <li>autoimmune diseases</li> <li>atherosclerosis</li> <li>immunotherapy</li> <li>glomerular disease</li> <li>chronic inflammation</li> <li>vasculitis</li> <li>Wegener's granulomatosis</li> <li>ANCA

23 Feb 2024: lupus erythematosus</li> <li>autoimmune diseases</li> <li>atherosclerosis</li> <li>immunotherapy</li> <li>glomerular disease</li> <li>chronic inflammation</li> <li>vasculitis</li> <li>Wegener's granulomatosis</li> <li>ANCA

23 Feb 2024: lupus erythematosus</li> <li>autoimmune diseases</li> <li>atherosclerosis</li> <li>immunotherapy</li> <li>glomerular disease</li> <li>chronic inflammation</li> <li>vasculitis</li> <li>Wegener's granulomatosis</li> <li>ANCA

23 Feb 2024: lupus erythematosus</li> <li>autoimmune diseases</li> <li>atherosclerosis</li> <li>immunotherapy</li> <li>glomerular disease</li> <li>chronic inflammation</li> <li>vasculitis</li> <li>Wegener's granulomatosis</li> <li>ANCA

23 Feb 2024: lupus erythematosus</li> <li>autoimmune diseases</li> <li>atherosclerosis</li> <li>immunotherapy</li> <li>glomerular disease</li> <li>chronic inflammation</li> <li>vasculitis</li> <li>Wegener's granulomatosis</li> <li>ANCA

23 Feb 2024: lupus erythematosus</li> <li>autoimmune diseases</li> <li>atherosclerosis</li> <li>immunotherapy</li> <li>glomerular disease</li> <li>chronic inflammation</li> <li>vasculitis</li> <li>Wegener's granulomatosis</li> <li>ANCA

23 Feb 2024: Primary Care Unit. The Listen Study. Title:. Listening: Involving SLE (Systemic Lupus Erythematosus) patients to empower and negotiate recognition. ... Collaborative:. Professor Stephen Sutton (University of Cambridge). Funding information. Funding

HE@Cam Seminar: Tray Brown – Building a Discrete Event Simulation to Determine the Cost-Effectiveness of Treatments for Systemic Lupus Erythematosus – Tray Brown -Department of Public Health and Primary care.

23 Feb 2024: Cambridge Immunology Network - Transplantation https://www.immunology.cam.ac.uk/Networkdirectory/research-themes/transplantation Understanding and minimising transplant rejection Organ transplantation involves the transfer of an organ from one

{"id":11936,"date":"2018-04-19T10:40:05","date_gmt":"2018-04-19T09:40:05","guid":{"rendered":"https://www2.mrc-lmb.cam.ac.uk/?p=11936"},"modified":"2019-02-07T12:41:42","modified_gmt":"2019-02-07T12:41:42","slug":"understanding-how-trim21-is-regulate

23 Feb 2024: Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake.

23 Feb 2024: RS, Murphy MP, Siegel RM, Clatworthy MR.u00a0/spanMacrophage metabolic reprogramming presents a therapeutic target in lupus nephritis.

{"id":14777,"date":"2019-07-10T09:30:53","date_gmt":"2019-07-10T08:30:53","guid":{"rendered":"https://www2.mrc-lmb.cam.ac.uk/?p=14777"},"modified":"2019-07-10T09:30:53","modified_gmt":"2019-07-10T08:30:53","slug":"insights-into-how-kap1-silences-vira

{"id":4193,"date":"2013-01-07T13:50:34","date_gmt":"2013-01-07T13:50:34","guid":{"rendered":"http://www2.mrc-lmb.cam.ac.uk/wordpress/research/technology-transfer/history-of-technology-transfer/"},"modified":"2023-07-21T12:49:41","modified_gmt":"2023-

23 Feb 2024: Cambridge Immunology Network - Molecular Immunity Unit- Department of Medicine https://www.immunology.cam.ac.uk/departments/miu Molecular Immunity Unit at the MRC Laboratory of Molecular Biology Infectious diseases remain the major cause of

H153832 a large X-ray source in Lupus, near l=340, b=18 was identified as a possible SNR by Riegler, Agrawal & Gull (1980), see also Colomb, Dubner & Giacani (1984), Gahm